RNI TC No. MAHENG14628 Date of Publication - 30.11.2023 RNI NO. DELENG/2004/13061 Date of Posting - 1.12.2023
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
From Exponential Growth to PHARMA BOOM
The Indian pharmaceutical industry is experiencing a dynamic growth landscape, marked by strategic initiatives such as partnerships, investments, Memoranda of
Understanding (MoUs), and collaborations. Despite geopolitical uncertainties like the Israel-Palestine and Russia-Ukraine conflicts lingering in 2023, the healthcare and pharma sector in India continues to gain momentum through new investments
and collaborative efforts. Major global players are actively engaging in partnerships, MoUs, and collaborations to secure a substantial global market share. In 2023 alone, more than 30 partnerships, MoUs and other collaborations have been forged to boost India’s pharmaceutical growth trajectory. The Indian pharmaceutical products market is projected to hit $130 billion by the end of 2030.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search